OSR Holdings, Inc.

OSR Holdings, Inc. is a U.S.-based healthcare and life sciences company with operations centered on medical device distribution through its subsidiary RMC and development-stage activities in healthcare technology. The company also holds interests in emerging businesses and financing initiatives tied to healthcare innovation and blockchain-based capital formation.

22

0.16

0.12

— OSR Holdings, Inc.
%
Medical device distribution70% Distribution of medical devices and related products through RMC.
Commission revenue20% Sales commissions recognized under consignment-based supplier arrangements.
Healthcare technology development5% Development-stage work on noninvasive glucose monitoring and related products.
Corporate and financing initiatives5% Tokenization and capital-markets initiatives supporting the company structure.

OSR Holdings serves healthcare customers that purchase medical devices through RMC, including parties that need...

  • Medical device buyersprimary

    Healthcare customers and intermediaries that buy distributed medical devices from RMC for clinical or operational use.

  • Supplier partnersprimary

    Major suppliers that place products under consignment and receive commission-based economics rather than traditional resale.

  • Healthcare technology userssecondary

    Potential future customers for noninvasive glucose monitoring and related development-stage products.

  • Capital markets counterpartiessecondary

    Investors and financing partners involved in equity issuance, ELOC, notes, and tokenization structures.

OSR Holdings is organized in the United States, but the available disclosures emphasize subsidiary-level operations...

  • •United States is the company’s home market and reporting base
  • •RMC drives operating activity through medical device distribution
  • •Healthcare technology development is tied to subsidiary operations
  • •Swiss-linked partnership adds cross-border financing exposure
  • •No country-level revenue split was disclosed in the excerpts

OSR Holdings is pursuing a dual-track strategy that combines healthcare operating assets with development-stage...

01
Stabilize and expand RMC distribution economicsshort-term

RMC is the main operating revenue source, so supplier terms directly affect revenue quality and margin stability.

02
Advance healthcare technology developmentmedium-term

Development assets such as noninvasive glucose monitoring create longer-term growth optionality beyond distribution.

03
Secure flexible financingshort-term

The company relies on external capital to fund operations and development programs.

04
Explore tokenized equity structuresmedium-term

Tokenization is intended to widen investor access and improve capital formation flexibility.

OSR Holdings faces execution risk from its dependence on a small operating base, development-stage healthcare programs,...

critical

Financing and liquidity risk

The company has recurring operating losses and depends on equity, debt, and ELOC funding to continue operations.

Scope
ELOC, convertible bonds, affiliate loans
Materiality
high
high

Dependence on a single operating subsidiary

Most net sales and gross profit are derived from RMC, so any disruption there would affect the whole company.

Scope
RMC medical device distribution
Materiality
high
high

Supplier concentration and contract transition risk

A major supplier relationship moved from resale to consignment, changing revenue timing and economics.

Scope
Medical device distribution contracts
Materiality
high
high

Development-stage product risk

R&D programs such as noninvasive glucose monitoring may fail technically, clinically, or commercially.

Scope
Healthcare technology pipeline
Materiality
medium
medium

Capital-markets and tokenization execution risk

Tokenized equity structures depend on regulatory approval, investor adoption, and operational implementation.

Scope
Regulation D tokenization roadmap
Materiality
medium
Revenue recognition under consignment arrangements
Affects net sales and gross margin
One-time merger-related expenses
Affects operating loss and pre-tax loss
R&D expense recognition
Affects operating loss and cash burn
Equity line of credit and warrant accounting
Affects share count and financing proceeds

GoodRx Holdings, Inc.

GDRX · Services-Computer Processing & Data Preparation

OSI SYSTEMS INC

OSIS · Semiconductors & Related Devices

IR-Med, Inc.

Electromedical & Electrotherapeutic Apparatus

Orchestra BioMed Holdings, Inc.

OBIO · Surgical & Medical Instruments & Apparatus

RetinalGenix Technologies Inc.

RTGN · Surgical & Medical Instruments & Apparatus

VASO Corp

VASO · Electromedical & Electrotherapeutic Apparatus

: 29/04/2026